eNauka - pregled
Pregled prema Autor Moiseenko, Fedor
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2025 | Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations | Moiseenko, Fedor; Radulovic, Marko; ...; (broj, koautora 18) | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2022 | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial | Verschraegen, Claire; Andric, Zoran G   ; Moiseenko, Fedor; Makharadze, Tamta; Shevnya, Sergii; Oleksiienko, Alona; Ruiz, Eduardo Yanez; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong;
Park, Sijin; Ju, Hana; Ohe, Yuichiro;
| Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |